4
Changes in Ownership
Tyra Biosciences, Inc. Filed Acc 0000950170-24-013474
Chief Operating Officer sold 9,587 shares at $18.09 ($173,466)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bensen Daniel Chief Operating Officer | 2024-02-07 | Sale 10b5-1 | −9,587 | $18.09 | $173,466 | 452,981 | D |
| Open-market sales · 9,587 sh · avg $18.09 · $173,466 | |||||||
Loading xslF345X05/ownership.xml…